Future Medicine: Biomarkers in Medicine This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Pharmacogenomic biomarkers in coronary artery disease: a narrative review
Biomark Med. 2024 Mar 8. doi: 10.2217/bmm-2023-0476. Online ahead of print.ABSTRACTCoronary artery disease (CAD) has a high mortality rate. Despite various therapeutic targets, non-responsiveness to drugs remains a prevalent issue. Pharmacogenomics assesses the way an individual's genetic attributes affect their likely response to drug therapy. Single-nucleotide polymorphisms play a crucial role in determining these outcomes. This review offers an overview of single-nucleotide polymorphisms investigated in clinical studies and their associations with drug response/nonresponse in the treatment of CAD. A total of 104 studies...
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Pamila Dua Sandeep Seth Bhavana Prasher Mitali Mukerji Subir Kumar Maulik K H Reeta Source Type: research
Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease
Conclusion: LAP is an ideal biomarker of hepatic steatosis and NAFLD.PMID:38456353 | DOI:10.2217/bmm-2023-0725 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Qiaoli Huang Xuying Tan Qiongmei Wu Hanqing Zhao Hangjun Chen Xinxue Yu Jinting Wang Xueyi Huang Yurong Huang Jun Wei Feng Wu Huilian Zhu Lijun Wang Source Type: research
Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia
Conclusion: Increased levels of miR-4793-3p and miR-1180-3p may indicate severe pneumonia development. Plasma miRNA profiling enables early prediction of severe CAP, aiding therapeutic decisions.PMID:38456294 | DOI:10.2217/bmm-2023-0463 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Rong Chai Cihang Zhou Zhenli Hu Jingjing Hu Source Type: research
Pharmacogenomic biomarkers in coronary artery disease: a narrative review
Biomark Med. 2024 Mar 8. doi: 10.2217/bmm-2023-0476. Online ahead of print.ABSTRACTCoronary artery disease (CAD) has a high mortality rate. Despite various therapeutic targets, non-responsiveness to drugs remains a prevalent issue. Pharmacogenomics assesses the way an individual's genetic attributes affect their likely response to drug therapy. Single-nucleotide polymorphisms play a crucial role in determining these outcomes. This review offers an overview of single-nucleotide polymorphisms investigated in clinical studies and their associations with drug response/nonresponse in the treatment of CAD. A total of 104 studies...
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Pamila Dua Sandeep Seth Bhavana Prasher Mitali Mukerji Subir Kumar Maulik K H Reeta Source Type: research
Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease
Conclusion: LAP is an ideal biomarker of hepatic steatosis and NAFLD.PMID:38456353 | DOI:10.2217/bmm-2023-0725 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Qiaoli Huang Xuying Tan Qiongmei Wu Hanqing Zhao Hangjun Chen Xinxue Yu Jinting Wang Xueyi Huang Yurong Huang Jun Wei Feng Wu Huilian Zhu Lijun Wang Source Type: research
Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia
Conclusion: Increased levels of miR-4793-3p and miR-1180-3p may indicate severe pneumonia development. Plasma miRNA profiling enables early prediction of severe CAP, aiding therapeutic decisions.PMID:38456294 | DOI:10.2217/bmm-2023-0463 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Rong Chai Cihang Zhou Zhenli Hu Jingjing Hu Source Type: research
Pharmacogenomic biomarkers in coronary artery disease: a narrative review
Biomark Med. 2024 Mar 8. doi: 10.2217/bmm-2023-0476. Online ahead of print.ABSTRACTCoronary artery disease (CAD) has a high mortality rate. Despite various therapeutic targets, non-responsiveness to drugs remains a prevalent issue. Pharmacogenomics assesses the way an individual's genetic attributes affect their likely response to drug therapy. Single-nucleotide polymorphisms play a crucial role in determining these outcomes. This review offers an overview of single-nucleotide polymorphisms investigated in clinical studies and their associations with drug response/nonresponse in the treatment of CAD. A total of 104 studies...
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Pamila Dua Sandeep Seth Bhavana Prasher Mitali Mukerji Subir Kumar Maulik K H Reeta Source Type: research
Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease
Conclusion: LAP is an ideal biomarker of hepatic steatosis and NAFLD.PMID:38456353 | DOI:10.2217/bmm-2023-0725 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Qiaoli Huang Xuying Tan Qiongmei Wu Hanqing Zhao Hangjun Chen Xinxue Yu Jinting Wang Xueyi Huang Yurong Huang Jun Wei Feng Wu Huilian Zhu Lijun Wang Source Type: research
Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia
Conclusion: Increased levels of miR-4793-3p and miR-1180-3p may indicate severe pneumonia development. Plasma miRNA profiling enables early prediction of severe CAP, aiding therapeutic decisions.PMID:38456294 | DOI:10.2217/bmm-2023-0463 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Rong Chai Cihang Zhou Zhenli Hu Jingjing Hu Source Type: research
Pharmacogenomic biomarkers in coronary artery disease: a narrative review
Biomark Med. 2024 Mar 8. doi: 10.2217/bmm-2023-0476. Online ahead of print.ABSTRACTCoronary artery disease (CAD) has a high mortality rate. Despite various therapeutic targets, non-responsiveness to drugs remains a prevalent issue. Pharmacogenomics assesses the way an individual's genetic attributes affect their likely response to drug therapy. Single-nucleotide polymorphisms play a crucial role in determining these outcomes. This review offers an overview of single-nucleotide polymorphisms investigated in clinical studies and their associations with drug response/nonresponse in the treatment of CAD. A total of 104 studies...
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Pamila Dua Sandeep Seth Bhavana Prasher Mitali Mukerji Subir Kumar Maulik K H Reeta Source Type: research
Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease
Conclusion: LAP is an ideal biomarker of hepatic steatosis and NAFLD.PMID:38456353 | DOI:10.2217/bmm-2023-0725 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 8, 2024 Category: Internal Medicine Authors: Qiaoli Huang Xuying Tan Qiongmei Wu Hanqing Zhao Hangjun Chen Xinxue Yu Jinting Wang Xueyi Huang Yurong Huang Jun Wei Feng Wu Huilian Zhu Lijun Wang Source Type: research
PLK4 reflects extrathyroidal invasion, high tumor stage and poor prognosis in papillary thyroid carcinoma patients
Conclusion: Tumor PLK4 reflects extrathyroidal invasion, higher tumor stage and shortened survival in PTC.PMID:38440866 | DOI:10.2217/bmm-2023-0565 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 5, 2024 Category: Internal Medicine Authors: Xiaonan Hu Jiawei Yu Mengshi Chen Rui Pang Source Type: research
Linkage of CDC42 and T-helper cell ratio with anxiety, depression and quality of life in ST-elevation myocardial infarction
Conclusion: CDC42 correlates with reduced Th1/Th2 and Th17/Treg ratios, reduced anxiety and depression, and improved quality of life in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.PMID:38440868 | DOI:10.2217/bmm-2023-0712 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 5, 2024 Category: Internal Medicine Authors: Xuechao Wang Junjie Feng Shaohua Luan Yong Zhou Shipan Zhang Hongling Su Zhongyu Wang Source Type: research
C-reactive protein to albumin ratio may predict in-hospital mortality in non-ST elevation myocardial infarction
Conclusion: This study revealed that CAR is an inexpensive and significant factor in predicting in-hospital mortality in patients undergoing percutaneous coronary intervention for NSTEMI.PMID:38440872 | DOI:10.2217/bmm-2023-0682 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 5, 2024 Category: Internal Medicine Authors: Tu ğba S Menekşe İlker Kaçer Muhammet Hac ımustafaoğlu Murat G ül Can Ate ş Source Type: research
Study on red blood cell distribution width in children with severe < em > Mycoplasma pneumoniae < /em > pneumonia
Conclusion: This study revealed that RDW could be correlated with the long-term prognosis and severity of severe MPP.PMID:38440878 | DOI:10.2217/bmm-2023-0671 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - March 5, 2024 Category: Internal Medicine Authors: Lin Wu Jinyan Zhang Hui-Min Zhang Cheng-Yi Wang Source Type: research